Zouboulis, C. C., Okun, M. M., Gniadecki, R., Foley, P. A., Lynde, C., Weisman, J., Karunaratne, P., & Williams, D. A. (2017). Adalimumab Efficacy in Hidradenitis Suppurativa Patients is Sustained at Least Three Years with Weekly Dosing: Results from a Phase 3 Open-Label Extension Study (PIONEER). SKIN The Journal of Cutaneous Medicine, 1(3.1), s128. https://doi.org/10.25251/skin.1.supp.127